ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 44

Validation of New Genes Identified in a Molecular Bayesian Network of Rheumatoid Arthritis Synovitis

Teresina Laragione1, Carolyn Harris 1, Wenhui Wang 1, Jun Zhu 1 and Percio Gulko 1, 1Icahn School of Medicine at Mount Sinai, New York, NY

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Fibroblasts, joint damage, rheumatoid arthritis, severity and Gene Expression, synovium

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: We have previously identified new key regulators of Rheumatoid arthritis (RA) synovial pathology using a systems biology approach that combined RA gene expression datasets, epigenomics data, genetics and rodent studies. The RA fibroblast-like synoviocytes (RA-FLS) have a central role in RA pathogenesis and joint damage, and their in vitro invasive properties correlate with in vivo joint damage. In the present study were examine the effect of different key regulators identified in the systems biology study in phenotypes relevant to disease and joint damage.

Methods: RA-FLS cell lines (n=4-6 cell lines per gene) were treated with siRNA smartpool targeting the top key network and subnetwork regulators, and compared with control siRNA. RA-FLS were then examined in different in vitro phenotypes that strongly correlate with joint damage in RA and rodent models of RA. These phenotypes included FLS invasiveness, FLS proliferation, cell adhesion, the wound healing model, and IL-1b-induced expression and production of IL-1b, IL-6, TNFa and MMPs (MMP1, 2, 3 and 14).

Results: Knock down of LOXL2 and NUSAP with siRNA significantly decreased FLS invasiveness by 30% (p=0.03) and 60% (p=0.002), respectively, compared with siRNA control. RA-FLS mobility in the wound healing assay was inhibited by knock down of AKT3, BACH1 and DLX4 (p=0.008). Knock down of TRIM22, an interferon-induced protein involved in innate immunity, decreased the IL-1b-induced release of IL-6 (p=0.03). RA-FLS proliferation and adhesion were not affected by any of the siRNA tested.

Conclusion: This study validated new key regulators identified in our systems biology discovery approach generating potential new understanding of events regulating FLS behavior in RA and potential new targets for the development of new treatments aimed at reducing joint damage.


Disclosure: T. Laragione, None; C. Harris, None; W. Wang, None; J. Zhu, None; P. Gulko, None.

To cite this abstract in AMA style:

Laragione T, Harris C, Wang W, Zhu J, Gulko P. Validation of New Genes Identified in a Molecular Bayesian Network of Rheumatoid Arthritis Synovitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/validation-of-new-genes-identified-in-a-molecular-bayesian-network-of-rheumatoid-arthritis-synovitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-new-genes-identified-in-a-molecular-bayesian-network-of-rheumatoid-arthritis-synovitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology